Literature DB >> 25922753

Exhaled nitric oxide and disease progression in chronic obstructive pulmonary disease.

Mauro Maniscalco1.   

Abstract

Entities:  

Year:  2015        PMID： 25922753      PMCID： PMC4387412          DOI： 10.3978/j.issn.2072-1439.2015.01.19

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  6 in total

1.  Exhaled nitric oxide in patients with alpha 1 antitrypsin (AAT) deficiency.

Authors:  M Malerba; E Clini; A Radaeli; L Corda; L Pini; L Ceriani; V Grassi
Journal:  Monaldi Arch Chest Dis       Date:  2001-04

2.  Increased plasma and salivary nitrite and decreased bronchial contribution to exhaled NO in pulmonary arterial hypertension.

Authors:  Andrei Malinovschi; Dan Henrohn; André Eriksson; Jon O Lundberg; Kjell Alving; Gerhard Wikström
Journal:  Eur J Clin Invest       Date:  2011-02-25       Impact factor: 4.686

Review 3.  Biomarkers of progression of chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

4.  Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.

Authors:  Szabolcs Soter; Imre Barta; Balazs Antus
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

5.  Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.

Authors:  M Malerba; B Ragnoli; A Radaeli
Journal:  J Intern Med       Date:  2008-10-25       Impact factor: 8.989

Review 6.  Exhaled nitric oxide as a biomarker in COPD and related comorbidities.

Authors:  Mario Malerba; Alessandro Radaeli; Alessia Olivini; Giovanni Damiani; Beatrice Ragnoli; Paolo Montuschi; Fabio L M Ricciardolo
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.